X-111123112-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -15 ACMG points: 0P and 15B. BP4_ModerateBP6_Very_StrongBP7BS2
The NM_002578.5(PAK3):c.9C>T(p.Asp3=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000425 in 1,199,883 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 20 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.000045 ( 0 hom., 1 hem., cov: 22)
Exomes 𝑓: 0.000042 ( 0 hom. 19 hem. )
Consequence
PAK3
NM_002578.5 synonymous
NM_002578.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 2.81
Genes affected
PAK3 (HGNC:8592): (p21 (RAC1) activated kinase 3) The protein encoded by this gene is a serine-threonine kinase and forms an activated complex with GTP-bound RAS-like (P21), CDC2 and RAC1. This protein may be necessary for dendritic development and for the rapid cytoskeletal reorganization in dendritic spines associated with synaptic plasticity. Defects in this gene are the cause of a non-syndromic form of X-linked intellectual disability. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -15 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.29).
BP6
Variant X-111123112-C-T is Benign according to our data. Variant chrX-111123112-C-T is described in ClinVar as [Benign]. Clinvar id is 914027.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=2.81 with no splicing effect.
BS2
High Hemizygotes in GnomAdExome4 at 19 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PAK3 | NM_002578.5 | c.9C>T | p.Asp3= | synonymous_variant | 5/18 | ENST00000372007.10 | NP_002569.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PAK3 | ENST00000372007.10 | c.9C>T | p.Asp3= | synonymous_variant | 5/18 | 1 | NM_002578.5 | ENSP00000361077 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000450 AC: 5AN: 111041Hom.: 0 Cov.: 22 AF XY: 0.0000301 AC XY: 1AN XY: 33275
GnomAD3 genomes
AF:
AC:
5
AN:
111041
Hom.:
Cov.:
22
AF XY:
AC XY:
1
AN XY:
33275
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000328 AC: 6AN: 183102Hom.: 0 AF XY: 0.0000443 AC XY: 3AN XY: 67646
GnomAD3 exomes
AF:
AC:
6
AN:
183102
Hom.:
AF XY:
AC XY:
3
AN XY:
67646
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000422 AC: 46AN: 1088842Hom.: 0 Cov.: 28 AF XY: 0.0000535 AC XY: 19AN XY: 354890
GnomAD4 exome
AF:
AC:
46
AN:
1088842
Hom.:
Cov.:
28
AF XY:
AC XY:
19
AN XY:
354890
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000450 AC: 5AN: 111041Hom.: 0 Cov.: 22 AF XY: 0.0000301 AC XY: 1AN XY: 33275
GnomAD4 genome
AF:
AC:
5
AN:
111041
Hom.:
Cov.:
22
AF XY:
AC XY:
1
AN XY:
33275
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 29, 2022 | - - |
Intellectual disability, X-linked 30 Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at